在约旦的前列腺癌患者中AKT1基因的新突变
Ala'a Alasmar1, Zina Al-Alami2, Sima Zein3
1Department of Medical Laboratory Sciences, Faculty of Allied Medical Sciences, Al-Ahliyya Amman University, Amman 19328, Jordan.
Current issues in molecular biology
|September 27, 2024
概括
约旦的前列腺癌 (PC) 患者经常出现AKT1基因突变,特别是在4号外因子中,以及Pleckstrin同质 (PH) 域中的新突变. 常见的E17K热点突变不存在,这表明其他AKT1变化驱动PC的发展.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- AKT1瘤基因在PI3K/AKT1通路中起着关键作用,与各种癌症有关.
- 经常研究AKT1 E17K热点突变,但其发生率在前列腺癌 (PC) 中较低.
- 约旦PC患者AKT1突变的研究有限,特别是在E17K热点之外.
研究的目的:
- 在约旦PC患者中调查AKT1Pleckstrin同质 (PH) 域中的基因变异.
- 将基因查扩展到AKT1基因前体3和4,超出了常见的E17K热点.
- 确定该队列中AKT1突变的频率和类型.
主要方法:
- 基因组DNA从约旦的84个形式固定嵌 (FFPE) PC样本中提取.
- 聚合酶连锁反应 (PCR) 放大了向的AKT1基因第3和第4个特异体.
- 用DNA测序来识别目标外体内的遗传变异.
主要成果:
- 在4号外子中检测到AKT1突变的高频率,包括9个误解和2个同义突变.
- 在AKT1 PH域中发现了两种新的误解突变 (N53Y和Q59K).
- 在AKT1 E17K热点中没有发现任何突变;在外显子3中发现了两个同名突变.
结论:
- 在约旦的前列腺癌患者中,AKT1突变的患病率很高,与E17K热点不同.
- 在AKT1PH域中的新突变表明了驱动PC发展的替代机制.
- 对非热点AKT1突变的进一步研究对于了解PC病变的产生至关重要.
相关概念视频
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
02:38The Ras Gene
6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.2K
01:22PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
01:20The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
01:33Cancer-Critical Genes I: Proto-oncogenes
8.7K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.7K
01:39Mutations
81.0K
Overview
81.0K